Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Steady Performance Seen Continuing at Superior Plus Corp. (SPB:CN) (SUUIF) - Canaccord Genuity
-
Halo Labs Announces Closing of Business Combination Stock to Commence Trading on October 3rd (NEO:HALO)
-
Tesla shares jump after Musk settles with SEC
-
Behrman Capital Invests in kSARIA Corporation
-
Canaccord Genuity Downgrades Veeva Systems (VEEV) to Hold
-
Canaccord Genuity Downgrades Paycom Software (PAYC) to Hold
-
Americas Silver Corporation and Pershing Gold Corporation Announce Business Combination
-
Americas Silver Corporation and Pershing Gold Corporation Announce Business Combination
-
Belvedere Announces Second Tranche Closing of Non-Brokered Private Placement Undertaken in Connection With Proposed Change of Business Transaction
-
UPDATE: BlackBerry Limited (BB) PT Raised to $11 at Canaccord Genuity
-
Wayfair (W) PT Raised to $165 at Canaccord Genuity
-
Teladoc (TDOC) PT Raised to $94 at Canaccord Genuity
-
CalAmp Corp. (CAMP) PT Raised to $31 at Canaccord Genuity
-
CalAmp Corp. (CAMP) PT Raised to $31 at Canaccord Genuity
-
IQE plc: Total voting rights
-
Ericsson (ERIC) PT Raised to $9 at Canaccord Genuity
-
Final Results
-
Histogenics (HSGX) to Meet With FDA to Discuss NeoCart Phase 3 Clinical Trial Data, Potential Regulatory Pathway
-
Histogenics to Meet With FDA to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway
-
UPDATE: Aldeyra Therapeutics (ALDX) PT Raised to 'Street High' $35 at Canaccord Genuity
-
Absolute Announces Approval of Normal Course Issuer Bid
-
Catasys (CATS) PT Raised to $15 at Canaccord Genuity
-
Y-mAbs Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Cannabis Oil Producer Halo Labs Provides Business Update
-
Saturn Oil & Gas Provides Operational Update and Announces Appointment of Board Director
-
IQE plc: Issue of Equity
-
C21 Investments leads international cast of speakers at Cannabis Capital Convention in Amsterdam
-
TransGlobe Energy Corporation Announces an Operations Update
-
Euro Manganese Inc. Files Final Prospectus and Announces Initial Public Offerings in Canada and Australia
-
Pandora (P) PT Raised to $11 at Canaccord Genuity
-
Y-mAbs Therapeutics (YMAB) IPO Opens 67% Higher
-
Y-mAbs Therapeutics, Inc. Prices 6M Share IPO at $16/Sh
-
Y-mAbs Therapeutics Announces Pricing of Initial Public Offering
-
SI-BONE Files Registration Statement for Proposed Initial Public Offering
-
Darden Restaurants (DRI) PT Raised to $125 at Canaccord Genuity
-
IIROC Trade Resumption / L'OCRCVM permet la reprise de la negociation - CGGC.UN
-
IIROC Trading Halt / Suspension de la negociation par l'OCRCVM - CGGC.UN
-
Autodesk (ADSK) PT Raised to $180 at Canaccord Genuity
-
Nike's Kaepernick ad spurs spike in sold-out items
-
Publication of Prospectus
-
TransGlobe Energy Corporation Announces Director/PDMR Shareholding
-
TransGlobe Energy Corporation Announces CEO Succession and Opening of London, UK Office
-
Anaplan Files for Initial Public Offering
-
Canna 8 Investment Trust Completes Initial Public Offering
-
Adobe (ADBE) PT Raised to $290 at Canaccord Genuity
-
Canaccord Genuity Recommends Buying iRhythm (IRTC) 'Aggressively' on Weakness; PT to $100
-
Canada's maturing Big Weed hits up Europe hoping for expansion cash
-
Exact Sciences (EXAS) PT Raised to $87 at Canaccord Genuity
-
nLIGHT, Inc. Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
nLIGHT, Inc. Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

